Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

285693

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation or suspension (1)

Date

2024 (1)

Results for "[search-keyword]"

Search

Sponsor content

1 result(s) found, displaying 1 to 1

RANI 2 ranitidine 300mg (as hydrochloride) tablet blister pack (Suspension effective for 6 months. A decision was made to extend the suspension for a further 6 months in accordance with section 29E of the Act. )

17 December 2024

Cancellation or suspension

Regulatory action due to , effective 17/12/2024

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

285693

Type

Date

RANI 2 ranitidine 300mg (as hydrochloride) tablet blister pack (Suspension effective for 6 months. A decision was made to extend the suspension for a further 6 months in accordance with section 29E of the Act. )

Help us improve the Therapeutic Goods Administration site